The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression

Author(s): Gulick T, Cresci S, Caira T, Moore DD, Kelly DP

Abstract

Medium-chain acyl-CoA dehydrogenase (MCAD) catalyzes a pivotal reaction in mitochondrial fatty acid (FA) beta-oxidation. To examine the potential role of FAs and their metabolites in the regulation of MCAD gene expression, we measured MCAD mRNA levels in animals fed inhibitors of mitochondrial long-chain FA import. Administration of carnitine palmitoyltransferase I inhibitors to mice or rats resulted in tissue-limited increases in steady-state MCAD mRNA levels. HepG2 cell cotransfection experiments with MCAD promoter reporter plasmids demonstrated that this was a transcriptional effect mediated by the peroxisome proliferator-activated receptor (PPAR). The activity mapped to a nuclear receptor response element that functioned in a heterologous promoter context and specifically bound immunoreactive PPAR in rat hepatic nuclear extracts, confirming an in vivo interaction. PPAR-mediated transactions of this promoter and element were also induced by exogenously added FA and fibric acid derivatives. Induction of PPAR transactivation by perturbation of this discrete metabolic step is unusual and indicates that intracellular FA metabolites that accumulate during such inhibition can regulate MCAD expression and are likely candidates for PPAR ligand(s). These results dictate an expanded role for the PPAR in the regulation of FA metabolism.

Similar Articles

Mitochondrial dysfunction in obesity

Author(s): Bournat JC, Brown CW

Increased oxidative stress in obesity and its impact on metabolic syndrome

Author(s): Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, et al.

Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress

Author(s): Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM

Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats

Author(s): Khamaisi M, Potashnik R, Tirosh A, Demshchak E, Rudich A, et al.

Lipoic acid prevents body weight gain induced by a high fat diet in rats: effects on intestinal sugar transport

Author(s): Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Barber A, Martínez JA, et al.

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

Author(s): Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, et al.

Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes

Author(s): Soares AF, Guichardant M, Cozzone D, Bernoud-Hubac N, Bouzaïdi-Tiali N

Hypothalamic CB1 Cannabinoid Receptors Regulate Energy Balance in Mice

Author(s): Cardinal P, Bellocchio L, Clark S, Cannich A, Klugmann M, et al.

Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways

Author(s): Zhou L, Sutton GM, Rochford JJ, Semple RK, Lam DD, et al.

A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene

Author(s): Church C, Lee S, Bagg EA, McTaggart JS, Deacon R, et al.

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

Author(s): Kelley DE, He J, Menshikova EV, Ritov VB

Oxidative capacity and aging in human muscle

Author(s): Conley KE, Jubrias SA, Esselman PC

Mitochondrial function and apoptotic susceptibility in aging skeletal muscle

Author(s): Chabi B, Ljubicic V, Menzies KJ, Huang JH, Saleem A, et al.

Excessive loss of skeletal muscle mass in older adults with type 2 diabetes

Author(s): Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreau R, et al.